The U.S. Senate has a plan to improve drug development for rare disease patients. The exit of controversial CBER chief Vinay Prasad will help clear the path.

In 2025 it seemed the only certainty for biotech was more uncertainty. Biotech leaders conducted business as usual against the background of ongoing funding challenges and ever-increasing drug ...

Veterans: More homeless veterans could be forced into involuntary or institutional care under a new effort by the Trump ...

Nigeria has approved its first national policy on cosmetics safety and health after nearly two decades of stalled attempts. The policy was launched at the Sixty sixth National Council on Health in ...

Stakeholders in governance and civil society have called on women and Persons with Disabilities (PWDs) in Anambra State to rise above social, cultural and structural barriers that limit their ...

Geroscience examines the underlying biology of aging to delay chronic diseases and extend the healthy years of human life.

Clinical & Scientific Conference, researchers and clinicians are talking about the central role of patients, families, and caregivers in driving change for people living with neuromuscular diseases.

Barclays 28th Annual Global Healthcare Conference March 11, 2026 2:00 PM EDTCompany ParticipantsAdam Steensberg - President ...

Because of the patent cliff issue, companies are looking outwards. They’re buying other companies, especially those with cool new science, or forming alliances. This helps them fill the gap in their ...